Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade | Login | Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Ponezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade | Login | Ponezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Ponezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade | Login | Ponezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Ublituximab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade | Login | Ublituximab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Ublituximab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade | Login | Ublituximab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Narnatumab Biosimilar - Anti-MST1R, CD136 mAb - Research Grade | Login | Narnatumab Biosimilar - Anti-MST1R, CD136 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Narnatumab Biosimilar - Anti-MST1R, CD136 mAb - Research Grade | Login | Narnatumab Biosimilar - Anti-MST1R, CD136 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Zebra fish MCM5Nter Recombinant Protein | Login | Zebra fish MCM5Nter Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
Vascular endothelial growth factor A(VEGFA) | Login | Vascular endothelial growth factor A(VEGFA) | ||||||||||||||||
|
||||||||||||||||||
Beta-klotho(KLB) | Login | Beta-klotho(KLB) | ||||||||||||||||
|
||||||||||||||||||
BCR-ABL Protein / BCR/ABL p210 fusion protein (BCR/ABL fusion) | Login | BCR-ABL Protein / BCR/ABL p210 fusion protein (BCR/ABL fusion) | ||||||||||||||||
|
||||||||||||||||||
BCR/ABL p210 fusion protein (BCR/ABL fusion) | Login | BCR/ABL p210 fusion protein (BCR/ABL fusion) | ||||||||||||||||
|
||||||||||||||||||
T-cell surface glycoprotein CD8 alpha chain(CD8A) | Login | T-cell surface glycoprotein CD8 alpha chain(CD8A) | ||||||||||||||||
|
||||||||||||||||||
T-cell surface glycoprotein CD8 beta chain(CD8B) | Login | T-cell surface glycoprotein CD8 beta chain(CD8B) | ||||||||||||||||
|
||||||||||||||||||
CD70 antigen(CD70) | Login | CD70 antigen(CD70) | ||||||||||||||||
|
||||||||||||||||||
Discoidin domain-containing receptor 2(DDR2) | Login | Discoidin domain-containing receptor 2(DDR2) | ||||||||||||||||
|
||||||||||||||||||
EGFR protein / Epidermal growth factor receptor(EGFR) | Login | EGFR protein / Epidermal growth factor receptor(EGFR) | ||||||||||||||||
|
||||||||||||||||||
Glypican-3(GPC3) | Login | Glypican-3(GPC3) | ||||||||||||||||
|
||||||||||||||||||
HGF Protein / Hepatocyte growth factor(HGF) | Login | HGF Protein / Hepatocyte growth factor(HGF) | ||||||||||||||||
|
||||||||||||||||||
Histone H3.1(HIST1H3A) | Login | Histone H3.1(HIST1H3A) | ||||||||||||||||
|
||||||||||||||||||
IL6 Protein / Interleukin-6(IL6) | Login | IL6 Protein / Interleukin-6(IL6) | ||||||||||||||||
|
||||||||||||||||||
Interleukin-8(CXCL8) | Login | Interleukin-8(CXCL8) | ||||||||||||||||
|
||||||||||||||||||
JAK2 protein / Tyrosine-protein kinase JAK2(JAK2) | Login | JAK2 protein / Tyrosine-protein kinase JAK2(JAK2) | ||||||||||||||||
|
||||||||||||||||||
Keratin, type I cytoskeletal 19(KRT19) | Login | Keratin, type I cytoskeletal 19(KRT19) | ||||||||||||||||
|
||||||||||||||||||
MIF Protein / Macrophage migration inhibitory factor(MIF) | Login | MIF Protein / Macrophage migration inhibitory factor(MIF) | ||||||||||||||||
|